Search

everythinglearnresearchcommunity

for

Search:↓

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Amazigh women in Morocco have lost control of argan oil production to the state and businessmen, limiting their roles to nut cracking.

The FDA did not approve a testosterone drug because of safety concerns.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Combining dutasteride injections with oral minoxidil may improve hair regrowth more than using oral minoxidil alone.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

New dermatology leaders and events were announced.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The FDA rejected a testosterone drug again due to safety concerns.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

The EFSA maintained its view that spermidine's effect on hair growth is related to disease treatment and does not meet the health claim criteria.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.